M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Array BioPharma posts higher net loss of USD24.9m in Q3 fiscal 2014
Biopharmaceutical company Array BioPharma (NasdaqGM:ARRY) stated on Tuesday its net loss of USD24.9m (USD0.20 per share) for the third quarter of its fiscal year ending 30 June 2014.
This marks a drop in earnings when compared to a net loss of USD21.6m (USD0.19 per share) for the same...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives